Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1995 Mar;41(2):71–81. doi: 10.1007/BF01527402

Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines

Alexei F Kirkin 1, Troels Reichert Petersen 1, Anna Catharina Olsen 1, Li Li 1, Per thor Straten 1, Jesper Zeuthen 1,✉
PMCID: PMC11037630  PMID: 7656272

Abstract

Melanoma is a cancer where the immune system is believed to play an important role in the control of malignant cell growth. To study the variability of the immune response in melanoma patients, we derived melanoma cell lines from several HLA-A2+ and HLA-A2− patients. The melanoma cell lines studied were designated FM3, FM6, FM9, FM28, FM37, FM45, FM55P, FM55M1 and FM55M2 and were established from eight metastatic tumors as well as from one primary tumor from a total of seven different patients. On the basis of the ability of tumor cells to induce specific cytotoxic T lymphocytes (CTL) from peripheral blood lymphocytes (PBL) in mixed lymphocyte/tumor culture with HLA-A2+ melanoma cells, the FM3 cell line was characterized as highly immunogenic. To investigate the expression of different melanoma-associated antigens recognized by CTL on different melanoma cell lines, we selected the cell line FM3 for restimulation and further T cell cloning experiments. The lytic activity of CTL clones with good proliferative activity was examined using a panel of HLA-A2+ and HLA-A2− melanoma cell lines. None of the tested HLA-A2− melanoma cell lines were susceptible to lysis by the CTL clones, whereas allogeneic HLA-A2+ melanoma cell lines were lysed only by a few CTL clones. On the basis of their reactivity with different melanoma cell lines, it was possible to divide the present CTL clones into at least four groups suggesting the recognition of at least four different antigens. Three of these target structures probably are different from already-described HLA-A2-restricted melanoma-associated antigens, because their expression in the different melanoma cell lines do not correlate with the recognition of melanoma cells by these CTL. The results first indicate that poorly immunogenic melanoma cells may express melanoma-associated antigens, and also suggest that, by using CTL clones obtained against different HLA-class-I-matched melanoma cells, it is possible to define such antigens.

Key words: Melanoma, Melanoma-associated antigens, Cytolytic T cell clones, HLA-A2 Immunogenicity

References

  • 1.Altomonte M, Gloghini A, Bertola G, Gasparollo A, Carbone A, Ferrone S, Maio M. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res. 1993;53:3343. [PubMed] [Google Scholar]
  • 2.Anichini A, Fossati G, Parmiani G. Clonal analysis of cytotoxic T-lymphocytes response to autologous human metastatic melanoma. Int J Cancer. 1985;35:683. doi: 10.1002/ijc.2910350518. [DOI] [PubMed] [Google Scholar]
  • 3.Anichini A, Maccalli C, Mortarini R, Salvi S, Mazzocchi A, Squarcina P, Herlyn M, Parmiani G. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J Exp Med. 1993;177:989. doi: 10.1084/jem.177.4.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Anichini A, Mortarini R, Alberti S, Mantovani A, Parmiani G. T-cell-receptor engagement and tumor ICAM-1 upregulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis. Int J Cancer. 1993;53:994. doi: 10.1002/ijc.2910530623. [DOI] [PubMed] [Google Scholar]
  • 5.Bakker ABH, Schreurs MWJ, de Boer AJ, Kawakami Y, Rosenberg SA, Adema GJ, Figdor CG. Melanocyte lineagespecific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med. 1994;179:1005. doi: 10.1084/jem.179.3.1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Becker JC, Brabletz T, Czerny C, Termeer C, Bröcker EB. Tumor escape mechanisms from immunosurveillance-induction of unresponsiveness in a specific MHC-restricted CD4+ human T-cell clone by the autologous MHC class-II+ melanoma. Int Immunol. 1993;5:1501. doi: 10.1093/intimm/5.12.1501. [DOI] [PubMed] [Google Scholar]
  • 7.Becker JC, Schwinn A, Dummer R, Burg G, Bröcker EB. Lesion-specific activation of cloned human tumor-infiltrating lymphocytes by autologous tumor cells: induction of proliferation and cytokine production. J Invest Dermatol. 1993;101:15. doi: 10.1111/1523-1747.ep12358425. [DOI] [PubMed] [Google Scholar]
  • 8.Benathan M, Pararas C, Frenk E. Modulatory growth effects of 3T3 fibroblasts on cocultivated human melanoma cells. Anticancer Res. 1991;11:203. [PubMed] [Google Scholar]
  • 9.Bodmer H, Ogg G, Cotch F, McMichael A. Anti-HLA-A antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes. Nature. 1989;342:443. doi: 10.1038/342443a0. [DOI] [PubMed] [Google Scholar]
  • 10.Boël P, Wildman C, Sensi ML, Brasseur R, Renauld J-C, Coulie P, Boon T, Van der Bruggen P. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 1985;2:167. doi: 10.1016/s1074-7613(95)80053-0. [DOI] [PubMed] [Google Scholar]
  • 11.Brichard V, Van Pel A, Wölfel T, Wölfel C, De Plaen E, Lethé B, Coulie P, Boon T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med. 1993;178:489. doi: 10.1084/jem.178.2.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG, Bodmer WF. Tissue typing of the HLA-A from genomic DNA by sequence specific PCR: Comparison of HLA genotype genotype and surface expression on colorectal tumor lines. Proc Natl Acad Sci USA. 1993;90:2842. doi: 10.1073/pnas.90.7.2842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Castelli C, Storkus WJ, Maeurer MJ, Martin DM, Huang EC, Pramanik BN, Nagabhushan TL, Parmiani G, Lotze MT. Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8(+) cytotoxic T lymphocytes. J Exp Med. 1995;181:363. doi: 10.1084/jem.181.1.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Chen Q, Hersey P. MHC-restricted responses of CD8+ and CD4+ T-cell clones from regional lymph nodes of melanoma patients. Int J Cancer. 1992;51:218. doi: 10.1002/ijc.2910510209. [DOI] [PubMed] [Google Scholar]
  • 15.Chen LP, McGowan P, Ashe S, Johnston J, Li YW, Hellström I, Hellström KE. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J Exp Med. 1994;179:523. doi: 10.1084/jem.179.2.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  • 17.Coulie PG, Somville M, Lehmann F, Hainaut P, Brasseur F, Devos R, Roon T. Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells. Int J Cancer. 1992;50:289. doi: 10.1002/ijc.2910500220. [DOI] [PubMed] [Google Scholar]
  • 18.Coulie PG, Brichard V, Van Pel A, Wölfel T, Schneider J, Traversari C, Mattei S, De Plaën E, Lurquin C, Szikora J-P, Renauld J-C, Boon T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med. 1994;180:35. doi: 10.1084/jem.180.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Crowley NJ, Slingluff CL, Darrow TL, Seigler HF. Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2 matched allogeneic melanomas. Cancer Res. 1990;50:492. [PubMed] [Google Scholar]
  • 20.Crowley NJ, Darrow TL, Quinn-Allen MA, Seigler HF. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele. J Immunol. 1991;146:1692. [PubMed] [Google Scholar]
  • 21.Darrow TL, Slingluff CL, Seigler HF. The role of HLA class I antigens in recognition of melanoma cells by tumorspecific cytotoxic T lymphocytes. J Immunol. 1989;142:3329. [PubMed] [Google Scholar]
  • 22.Gaugler B, Van den Eynde B, Van der Bruggen P, Romero P, Gaforio JJ, De Olaen E, Lethé B, Brasseur F, Boon T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med. 1994;179:921. doi: 10.1084/jem.179.3.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hérin M, Lemoine C, Weynants P, Vessière F, Knuth A, Devos R, Boon T. Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int J Cancer. 1987;39:390. doi: 10.1002/ijc.2910390320. [DOI] [PubMed] [Google Scholar]
  • 24.Hermann GG, Zeuthen J, Claesson MH. LAK cell mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2. Cytotoxicity, target cell recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines. Nat Immun Cell Growth Regul. 1992;11:7. [PubMed] [Google Scholar]
  • 25.Hersey P, Si ZY, Smith MJ, Thomas WD. Expression of the co-stimulatory molecule B7 on melanoma cells. Int J Cancer. 1994;58:527. doi: 10.1002/ijc.2910580413. [DOI] [PubMed] [Google Scholar]
  • 26.Itoh K, Platsoucas CD, Balch CM. Autologous tumorspecific cytotoxic T-lymphocytes in the infiltrate of human metastatic melanomas: activation by interleukin-2 and autologous tumor cells, and involvement of the T cell receptor. J Exp Med. 1988;168:1419. doi: 10.1084/jem.168.4.1419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Johnston RF, Pickett SC, Barker DL. Autoradiography using storage phosphor technology. Electrophoresis. 1990;11:355. doi: 10.1002/elps.1150110503. [DOI] [PubMed] [Google Scholar]
  • 28.Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T, Rosenberg SA. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA. 1994;91:3515. doi: 10.1073/pnas.91.9.3515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kawakami Y, Eliyahu S, Delgado CH, Robbins PH, Sakaguchi K, Appella E, Yannelli JH, Adema GH, Miki T, Rosenberg SA. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA. 1994;91:6458. doi: 10.1073/pnas.91.14.6458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Knuth A, Wölfel T, Klehmann E, Boon T, Meyer zum Büschenfelde KH. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc Natl Acad Sci USA. 1989;86:2804. doi: 10.1073/pnas.86.8.2804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kwon BS, Haq AK, Pomerantz SH, Halaban R. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc Natl Acad Sci USA. 1987;84:7473. doi: 10.1073/pnas.84.21.7473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Muul LM, Spiess PJ, Director EP, Rosenberg SA. Identification of specific cytolytic immune response against autologous tumor in humans bearing malignant melanoma. J Immunol. 1987;138:989. [PubMed] [Google Scholar]
  • 33.Olsen AC, Fossum B, Kirkin AF, Zeuthen J, Gaudernack G. A human melanoma cell line, recognized by both HLA class I and class II restricted T cells, is capable of initiating both primary and secondary responses. Scand J Immunol. 1995;41:357. doi: 10.1111/j.1365-3083.1995.tb03579.x. [DOI] [PubMed] [Google Scholar]
  • 34.O'Neil BH, Kawakami Y, Restifo NP, Bennink JR, Yewdell JW, Rosenberg SA. Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLA. J Immunol. 1993;151:1410. [PMC free article] [PubMed] [Google Scholar]
  • 35.Ramarathinam L, Castle M, Wu Y, Liu Y. T-cell costimulation by B7/BB1 induces CD8 T-cell-dependent tumor rejection — an important role of B7/BB1 in the induction, recruitment, and effector function of anti-tumor T-cells. J Exp Med. 1994;179:1205. doi: 10.1084/jem.179.4.1205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Schwartz RH. Acquisition of immunological self-tolerance. Cell. 1989;57:1073. doi: 10.1016/0092-8674(89)90044-5. [DOI] [PubMed] [Google Scholar]
  • 37.Topalian S, Solomon D, Rosenberg SA. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J Immunol. 1989;142:3714. [PubMed] [Google Scholar]
  • 38.Topalian SL, Hom SS, Kawakami Y, Mancini M, Schwartzentruber DJ, Zakut R, Rosenberg SA. Recognition of shared melanoma antigens by human tumor-infiltrating lymphocytes. J Immunother. 1992;12:203. doi: 10.1097/00002371-199210000-00013. [DOI] [PubMed] [Google Scholar]
  • 39.Townsend SE, Allison JP. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science. 1993;259:368. doi: 10.1126/science.7678351. [DOI] [PubMed] [Google Scholar]
  • 40.Van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991;254:1643. doi: 10.1126/science.1840703. [DOI] [PubMed] [Google Scholar]
  • 41.Van der Bruggen P, Bastin J, Gajewski T, Coulie PG, Boël P, Desmet C, Traversari C, Townsend A, Boon T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol. 1994;24:3038. doi: 10.1002/eji.1830241218. [DOI] [PubMed] [Google Scholar]
  • 42.Vessière-Louveaux F, Darville M, Knuth A, Boon T. Use of irradiated mouse fibroblasts to improve the cloning and adaptation to culture of human melanoma cells. Int J Cancer. 1985;35:231. doi: 10.1002/ijc.2910350215. [DOI] [PubMed] [Google Scholar]
  • 43.Viret C, Davodeau F, Guilloux Y, Bignon JD, Semana G, Breathlach R, Jotereau F. Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes. Eur J Immunol. 1993;23:141. doi: 10.1002/eji.1830230123. [DOI] [PubMed] [Google Scholar]
  • 44.Wang RF, Robbins PF, Kawakami Y, Kang XQ, Rosenberg SA. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J Exp Med. 1995;181:799. doi: 10.1084/jem.181.2.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Wölfel T, Klehmann E, Müller C, Schütt K-H, zum Büschenfelde KHM, Knuth A. Lysis of human melanoma cells by an autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J Exp Med. 1989;170:797. doi: 10.1084/jem.170.3.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Wölfel T, Van Pel A, Brichard V, Schneider J, Seliger B, zum Büschenfelde KHM, Boon T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol. 1994;24:759. doi: 10.1002/eji.1830240340. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES